Renal Market Research Reports & Industry Analysis
Filter your search
Research Assistance
Renal Industry Research & Market Reports
-
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2018
... Review, H1 2018, provides an overview of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genito Urinary System And Sex Hormones) pipeline landscape. End-stage kidney disease is the complete or almost complete failure of ... Read More
-
Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2018
... stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides ... Read More
-
Renal Dialysis Equipment: Technologies and Global Markets
... report deals with various types of dialysis available, including hemodialysis, peritoneal dialysis and continuous renal replacement therapy (CRRT). The report looks at the various products used in dialysis, including standalone and portable dialysis equipment, dialysate, ... Read More
-
Global and Chinese Kidney Stone Punches Industry, 2018 Market Research Report
... the Chinese market. The report provides key statistics on the market status of the Kidney Stone Punches manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, ... Read More
-
Acute Renal Failure (ARF)- Epidemiology Forecast to 2027
... France and United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain and the United Kingdom) • Japan Study Period: 2016-2027 Acute Renal Failure Epidemiology The Acute Renal Failure ... Read More
-
Acute Renal Failure (ARF) - Market Insights, Epidemiology and Market Forecast-2027
... Failure in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size ... Read More
-
Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2018
... trials scenario. This report provides top line data relating to the clinical trials on Papillary Renal Cell Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2018
... an overview of the Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) pipeline landscape. Chronic kidney disease is the slow loss of kidney function over time. Signs and symptoms of kidney ... Read More
-
Polycystic Kidney Disease - Pipeline Review, H1 2018
... Disease (Genetic Disorders) pipeline landscape. Polycystic kidney disease (PKD) is a disorder in which clusters of cysts develop primarily within kidneys. Polycystic kidney disease symptoms may include high blood pressure, back or side pain, headache, ... Read More
-
Kidney Dialysis Centers
... Medical Care and B Braun Melsungen. COMPETITIVE LANDSCAPE Demand depends on the number of people who suffer from kidney disease. The profitability of individual companies is linked to efficient operations and good marketing. Large companies ... Read More
-
Global Dialysis Market: Industry Analysis & Outlook (2018-2022)
... to a machine to be cleaned, using a special fluid called dialysate, a mixture of pure water and chemicals, to pull wastes out of your blood without removing substances your body needs. There are two ... Read More
-
Global Renal Cluster Drug Market Research Report 2018
... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Renal Cluster Drug basics: ... Read More
-
Market Access Impact: Renal Cell Carcinoma (US) 2018
... all renal cell carcinoma (RCC) prescriptions in the US, certain brands are losing on market share. Is it yours? Find out what’s driving share gains, and what your brand can do to level the playing ... Read More
-
Global Renal Failure Partnering 2012 to 2018
... companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and ... Read More
-
Market Access Impact: Renal Cell Carcinoma (EU5) 2018
... cell carcinoma (RCC) prescriptions in Europe, certain brands are losing on market share. Is it yours? Find out what’s driving share gains, and what your brand can do to level the playing field in Market ... Read More
-
Renal Cell Carcinoma: Update Bulletin #3 [March 2018]
... Phase III IMmotion151 trial of atezolizumab (Tecentriq) in combination with Avastin (bevacizumab) in meeting its co-primary endpoint of investigator-assessed progression-free survival (PFS); AVEO Oncology and EUSA Pharma presenting positive preliminary findings from the Phase II ... Read More
-
Global Renal Biomarker Market - Segmented by Biomarker Type, Diagnostic Technique, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)
... CAGR during 2018-2023 (the forecast period). Kidney disease is a major cause of deaths worldwide. With the increasing incidences of chronic kidney diseases, especially, among the geriatric population, the need for novel biomarkers for early ... Read More
-
Medical Affairs Reputations: Renal Cell Carcinoma (EU5) 2018
... The 150 medical oncologists we polled say that nearly every team needs improvement in two or more areas, but are those targeted improvements enough to put your team ahead of the competition? Discover all the ... Read More
-
Medical Affairs Reputations: Renal Cell Carcinoma (US) 2018
... rival. The 100 medical oncologists we polled say that each of those teams needs improvement in at least one specific area, but are those targeted improvements enough to put your team ahead of the competition? ... Read More
-
The 2019-2024 World Outlook for Continuous Renal Replacement Therapy (CRRT)
... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More
-
The 2019-2024 World Outlook for Renal Cell Carcinoma (RCC) Drugs
... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More
-
NPS+ Renal Cell Carcinoma (EU5) 2018
... levels of loyalty and satisfaction than others – but why? What are the key factors driving physician choice and how does each of the leading brands compare to its competitors? NPS+ RCC (EU5) gives a ... Read More
-
NPS+ Renal Cell Carcinoma (US) 2018
... levels of loyalty and satisfaction than others – but why? What are the key factors driving physician choice and how does each of the leading brands compare to its competitors? NPS+ RCC (US) gives a ... Read More
-
The 2019-2024 World Outlook for Kidney Stone Management Devices
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018
... 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste products from ... Read More
